A study reported by nature.com finds that blocking p300/CBP drives apoptosis, or programmed cell death, in mouse embryos. The effect appears during the transition from the four-cell stage to the blastocyst, a critical window of early development. According to nature.com, the inhibition works by disrupting DNA repair tied to H1K75ac.
The research points to a chain of events: p300/CBP inhibition impairs H1K75ac-associated DNA repair, and that impairment precedes the rise in apoptosis. The findings were published on Saturday, October 3, 2026, according to the headline and summary from nature.com. No further details from the study were available in the source material.
The work centers on the four-cell-to-blastocyst transition, a period when the embryo undergoes substantial change and depends on intact DNA repair. H1K75ac, a modification the study links to that repair process, appears to be a point of vulnerability when p300/CBP activity is suppressed. The reported outcome is increased apoptosis in the embryos.
The findings are based on mouse embryos, and the source material does not indicate whether the results extend to other species.
What to watch next: whether follow-up research clarifies how H1K75ac-associated repair is regulated and whether these results hold beyond the mouse model.
